Latest Research And Development News

Page 30 of 82
Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.
Ada Torres
Ada Torres
29 Oct 2025
LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.
Ada Torres
Ada Torres
29 Oct 2025
Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.
Ada Torres
Ada Torres
29 Oct 2025
Nexus Minerals has reported significant new high-grade gold discoveries at its Wallbrook Gold Project, alongside progress in permitting its Crusader-Templar deposit for mining operations.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.
Ada Torres
Ada Torres
28 Oct 2025
Assetora Limited disclosed a $341,000 net operating cash outflow for the September 2025 quarter, supported by $1.6 million in total available funding including cash reserves and financing facilities.
Sophie Babbage
Sophie Babbage
28 Oct 2025
Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.
Ada Torres
Ada Torres
28 Oct 2025
CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.
Ada Torres
Ada Torres
28 Oct 2025
Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.
Ada Torres
Ada Torres
28 Oct 2025
NOVONIX has reached mutual agreement to draw down an additional US$40 million tranche of convertible debentures from Yorkville Advisors, advancing its funding strategy to support growth in battery technology.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Ardea Resources reports strong progress on its Kalgoorlie Nickel Project’s Definitive Feasibility Study, including high-grade drilling results, a heritage agreement, and consortium funding support. Completion of the DFS is now targeted for mid-2026 amid ongoing ESG and stakeholder engagement.
Maxwell Dee
Maxwell Dee
28 Oct 2025
EMVision Medical Devices has expanded its pivotal clinical trial sites, secured a $3 million government grant, and raised $14 million through placement and share purchase plan, positioning itself strongly for upcoming regulatory submissions and commercialisation.
Ada Torres
Ada Torres
28 Oct 2025